An Immune-Related Gene Signature for Predicting Neoadjuvant Chemoradiotherapy Efficacy in Rectal Carcinoma

BACKGROUND: Locally advanced rectal cancers (LARC) show a highly variable response to neoadjuvant chemoradiotherapy (nCRT), and the impact of the tumor immune response in this process is poorly understood. This study aimed to characterize the immune-related gene expression profiles (GEP), pathways,...

Descripción completa

Detalles Bibliográficos
Autores principales: Qian, Liwen, Lai, Xiaojing, Gu, Benxing, Sun, Xiaonan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121132/
https://www.ncbi.nlm.nih.gov/pubmed/35603163
http://dx.doi.org/10.3389/fimmu.2022.784479

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9121132/
https://www.ncbi.nlm.nih.gov/pubmed/35603163
http://dx.doi.org/10.3389/fimmu.2022.784479

Ejemplares similares